phase readout
saveNCT07575308: HMBeacon: A Phase 2 Study to Evaluate ALN-6400 in Adult and Adolescent Female Patients With VWD and HMB
NOT_YET_RECRUITINGupdated 14m ago
community read0 votes
Sponsor: Alnylam Pharmaceuticals. Phase: PHASE2. Conditions: Von Willebrand Disease (VWD), Heavy Menstrual Bleeding (HMB)
view source ↗
comments(0)
5-min edit window · permanent after that